|
U.S. FDA Commissioner: Transparency Needed Among International Regulators
PHILADELPHIA — The U.S. Food and Drug Administration (FDA) and international regulators must establish a much more collaborative framework in order to ensure the safety of the world’s drug supply chains, FDA Commissioner Margaret Hamburg says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
Poland Expands List of Reimbursed Drugs, Adds New Active SubstancesDrugmakers: Public Education Vital to EU Online Pharmacy Verification SchemeEU-Japan Float Criteria for Developing Drugs Using Block-Copolymer-MicellesEU Parliament Votes for Faster Generic Drug Pricing Decisions, Leaves New Drug Timelines Alone
|
Subscribe
Archives